Cardinal Health, Inc. (CAH) stock analysis

Healthcare · Medical Distribution

From the 10-K filed 2026-08-11

Business type: Franchise

How it makes money

It generates profit through a generic program where earnings peak immediately after product launches and branded distribution fees tied to manufacturer-set wholesale prices.

The Pharma segment drives the majority of results through two distinct mechanisms. For generic drugs, it captures the highest margins during the window immediately following a new product launch, after which prices and profits typically decay. For branded pharmaceuticals, it acts as a service provider where compensation is calculated as a specific percentage of the wholesale acquisition cost set by the manufacturers.

While high-demand products like GLP-1 medications significantly increased fiscal 2026 revenue by 14%, they did not meaningfully contribute to segment profit. Instead, earnings growth is increasingly tied to its Managed Service Organization (MSO) platforms, which provide high-touch support to specialty physician practices in oncology, urology, and gastroenterology.

What protects it: the moat

It secures its cost position through Red Oak Sourcing, a generic procurement venture with CVS Health, and locks in specialty volume through MSO platforms.

To maintain a competitive edge in generic pricing, it utilizes Red Oak Sourcing, a joint venture with its largest customer, CVS Health, to negotiate supply contracts for both companies. This scale allows it to secure better terms than it might obtain independently.

Furthermore, its expansion into the MSO space—specifically through The Specialty Alliance and Navista—creates a structural link to specialty physicians. By providing practice management and support services to over 750 providers, it embeds itself into the workflows of high-value specialty drug prescribers, protecting its specialty distribution volumes.

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

More on CAH

Other companies in Medical Distribution